首页>投融资
Vaccinex
上市后再融资
Vaccinex, Inc.于2001年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司,致力于发现和开发靶向生物治疗药物,以治疗严重疾病和未满足医疗需求的病症,包括癌症、神经退行性疾病和自身免疫性疾病。该公司正在利用他们的SEMA4D抗体平台和他们在SEMA4D生物学方面的广泛知识来开发主要候选产品pepinemab(也称为VX15/2503)。该公司专注于开发pepinemab,用于治疗某些癌症适应症,特别是头颈部鳞状细胞癌、胰腺癌和PDAC,以及神经退行性疾病,包括亨廷顿病和阿尔茨海默病。
基本信息
-
公司全称Vaccinex Inc
-
类型靶向生物疗法开发商
-
产业领域医药研发/制造
-
公司人数15~50人
-
地址1895 Mount Hope Avenue Rochester NY 14620
-
联系电话1-585-2712700
-
邮箱info@vaccinex.com
-
成立时间1997-01-01
投融资
-
2024-09-18上市后再融资620万美元ROTH Capital Partners
-
2024-02-07上市后再融资370万美元未透露
-
2023-09-28增发960万美元未透露
-
2023-04-03上市后再融资500万美元未透露
-
2020-03-31上市后再融资1650万美元未透露
-
2019-12-10上市后再融资300万美元Alzheimer's Drug Discovery Foundation
-
2018-08-09上市3720.0007万美元未透露
-
2017-06-30未透露600万美元未透露
- 加载更多
相关投融资企业
收并购
硕腾公司于2012年7月在美国特拉华州成立,是全球领先的最大的动物保健药和疫苗公司之一。作为开发、制造商业化的动物保健药品和疫苗的全球领导者,公司一直致力于提供解决方案来提高动物的健康。
战略投资
Medic Life Sciences Inc是一家美国的生物技术公司,专注于开发创新的医疗设备和诊断技术。公司致力于改善患者的诊断和治疗体验,通过提供高效、便捷的医疗产品和服务,满足医疗市场的需求。其主要产品线包括医疗影像设备、诊断试剂和生物信息学工具等,通过不断的技术创新和市场拓展,为全球患者带来更好的医疗健康
收并购
Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides, biologics and biomarkers.
Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means less complications helping the rapid development of new drugs.
We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report.
As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today.
Visit our website at www.alderleyanalytical.com for more information.